FlandersBio on Twitter

Follow us on Twitter

Life sciences database

Databank life sciences

in het nederlands in english

FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.

FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.

Sanofi Belgium

Website: http://www.genzyme.be
Phone: +32 14 56 49 11
FlandersBio Member
More address details

Business Focus

Genzyme is a global biopharmaceutical company helping patients in more than 100 countries. Genzyme is Sanofi’s global center of excellence in rare diseases and multiple sclerosis (MS). In Geel, Belgium, Genzyme has a manufacturing facility to produce therapeutic protein products through cell culture. The main product is recombinant alpha-glucosidase, the enzyme replacement therapy for Pompe disease, a rare genetic, often fatal, disease of the muscle.


Company Profile

Genzyme's commitment to innovation continues today with research into novel approaches to genetic disease, heart disease, and other areas of unmet medical need. Genzyme employees in offices around the globe serve patients in over 100 countries.

Genzyme BVBA founded in 2001 located in Geel, a large manufacturing site for biopharmaceuticals (employees >530).

Science & Technology or Services

Genzyme has strong development programs using multiple technologies to genetic diseases, cardiovascular diseases, and immune diseases. In research and development, the company takes a pragmatic approach that gives freedom to apply diverse technologies to specific medical areas. These technologies include proteins, polymers, small molecules, biomaterials, cell therapy and gene therapy.

Product description

Personalized Genetic Health and Cardiovascular:

  • Enzyme replacement treatment for Type 1 Gaucher disease.
  • Enzyme replacement treatment for Fabry disease.
  • Enzyme replacement treatment for Mucopolysaccharidosis I (MPS I).
  • Enzyme replacement treatment for Pompe disease.


Genzyme seeks strategic collaborations to expand its portfolio of commercialized products and services, to supplement its product pipeline, and to access complementary research, technology, and development capabilities. The company focuses on first-rate science and on opportunities that address well-defined patient populations with unmet or underserved medical need.

Some major partnerships:

  • Biomarin - enzyme replacement therapy for Mucopolysaccharidosis type I
  • Isis Pharmaceutical: Developing Mipomersen for high risk cardiovascular disease

More info

Address: Cipalstraat 8
2440 Geel

Route: Via Google Maps
Website: http://www.genzyme.be

Phone: +32 14 56 49 11
Fax: +32 14 56 49 80
Foundation date: 1/2001
Email: luc.kupers@genzyme.com

Become a Member

Listen to some testimonials from companies that are a member of FlandersBio and discover the benefits of membership

Read more

Z Life Sciences

Looking behind the scenes of the vibrant life sciences sector in Flanders!



Belgian biotech on Euronext

Belgian biotech on Euronext

FlandersBio Members

Galapagos Flen Pharma Cortexpert Odyscience SGS Insilico Genomics Quality Assistance Lodilat (Ocasa) Janssen Infectious Diseases - Diagnostics Millibeter Novellas Healthcare UgenTec GrayMatters Consulting Brunel Consultants SynAbs Tobeas Alexion Pharma Belgium BVBA MDxHealth Cochlear Technology Centre Belgium Sofrigam Medanex Clinic SVR-ARCHITECTS PMV Emtex The Clinical Company Korn Ferry - Hay Group ISMS Ablynx icoMetrix 2 Bridge

View all members

Life Sciences Map

Life Sciences Map

View Life Sciences Map

Back to top